Friday 6 November 2026 Export LGND’s income statement to Excel — free account

Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $268.1 million, up 60.4% from fiscal 2024.

Revenue: −31.8%
EPS: −123.8%
Free cash flow: −268.5%
Total debt: +153.3%

Quarter to September 2026, against a year earlier

306.43 7.43 +2.48%

Follow LGND

Alert me

Market cap: $6.0B
P/E: 118×
Fwd P/E: 88.3×
Dividend yield: —
F-score: 6/9
Altman Z: 5.45
Beneish M: −4.02
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	4	5	6	6	+8 more TTM periods Free account
ROE Full definition →	5.38%	21.96%	17.13%	13.47%
ROA Full definition →	2.77%	12.58%	12.60%	9.95%
ROIC Full definition →	0.91%	8.19%	9.06%	3.62%
Return on Tangible Assets Full definition →	10.48%	13.98%	18.62%	15.66%
Average Days of Receivables Full definition →	119.67	87.84	72.87	83.12
Free Cash Flow per Share Full definition →	4.04	7.15	6.77	3.15
Free Cash Flow Full definition →	80.58	143.37	134.59	60.91
Capital Expenditures Full definition →	(10.45)	11.65	11.09	11.56
Other line items
Cash ROIC Full definition →	3.18%	4.14%	6.02%	2.74%
Accounts Receivable Turnover Full definition →	3.59	4.75	5.62	5.18
Accounts Payable Turnover Full definition →	0.56	1.48	2.44	3.44
Inventory Turnover Full definition →	0.92	1.03	0.93	1.25
Average Days of Payables Full definition →	1,196.50	258.50	148.10	81.23
Days of Inventory on Hand Full definition →	436.59	282.08	373.24	228.95
Tax Rate Full definition →	(0.02)	(0.17)	(0.17)	(0.22)
Research and Development Expense of Revenue Full definition →	9.10%	14.23%	12.11%	30.28%
Selling, General and Administrative Expense of Revenue Full definition →	58.15%	35.60%	34.42%	34.48%
Share Based Compensation of Revenue Full definition →	22.34%	18.33%	18.07%	17.48%
Interest Coverage Full definition →	2.94	15.30	16.91	8.70
Operating CF/Net income Full definition →	1.77	0.67	0.80	0.40
Depreciation/Fixed assets Full definition →	0.00	0.00	0.00	0.00
Capex/Depreciation Full definition →	(0.31)	0.40	0.38	0.38
Revenue per Share Full definition →	12.72	14.48	13.80	13.86
Operating CF per Share Full definition →	4.56	6.57	6.21	2.55
Capex per Share Full definition →	(0.52)	0.58	0.56	0.60
Capex to Sales Full definition →	0.04	(0.04)	(0.04)	(0.04)

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly